
Careers and Opportunities | Careers | Mallinckrodt Pharmaceuticals
A company with a start-up mentality and a history that spans more than 150 years, Mallinckrodt is an industry leader with an exceedingly capable, engaged workforce. Come grow your career …
Mallinckrodt - Wikipedia
Mallinckrodt Pharmaceuticals plc is an American-Irish domiciled manufacturer of specialty pharmaceuticals (namely, adrenocorticotropic hormone), generic drugs and imaging agents. …
Mallinckrodt Pharmaceuticals | Global Specialty Pharmaceutical …
As a global specialty pharmaceutical company, Mallinckrodt has been making the complex simple for more than 150 years. Visit the website to learn more.
Our Products | Mallinckrodt Pharmaceuticals
Mallinckrodt has a diverse portfolio of branded products available across a broad range of indications and a broad line of speciality generics. Visit our website to learn about our product …
Mallinckrodt's opioid creditors support fast-track second …
2023年8月30日 · Drugmaker Mallinckrodt's opioid creditors will support an expedited second bankruptcy, despite a "gruesome" $1 billion reduction in settlement money for victims of the …
Mallinckrodt Pharmaceuticals - LinkedIn
Mallinckrodt Pharmaceuticals is pleased to announce the launch of its 2025 Internship Program. The U.S. program will commence the week of May 19th and will continue through August 1st.
Home - Mallinckrodt Customer Portal
Updated Mallinckrodt Statement on Extended-Release Methylphenidate Tablets. Our personalized customer portal allows you to view shipment information and track status, find …
Mallinckrodt Group Inc. -- Company History
Working in their favor was the fact that St. Louis was fast becoming a major commercial center because of the railroad and the development of the Mississippi River. As the only chemical …
Specialty Generics | Mallinckrodt Pharmaceuticals
Mallinckrodt is uniquely suited to help strengthen the US pharmaceutical supply chain with its five US-based manufacturing sites and the capability to manufacture both API and finished dose …
affecting Mallinckrodt’s businesses and any other statements regarding events or developments that the company believes or antic ipates will or may occur in the future, may be "forward- …